Intravenous Glibenclamide for Cerebral Oedema after Large Hemispheric Stroke (CHARM): a Phase 3, Double-Blind, Placebo-Controlled, Randomised Trial
LANCET NEUROLOGY(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined